Wellcome Leap and Medicines360 Partner to Advance Maternal Health Tools Globally
Wellcome Leap and Medicines360 have partnered to develop affordable tools to detect pregnancy complications earlier and reduce stillbirths worldwide.
Wellcome Leap and Medicines360 have partnered to develop affordable tools to detect pregnancy complications earlier and reduce stillbirths worldwide.
In this episode, we’re joined by Dr. Renee Wittemyer, vice president of program strategy at Pivotal Ventures, and Dr. Regina Dugan, CEO of Wellcome Leap. They discuss the organizations’ recent $100 million commitment to accelerate women’s health research.
Arbiter’s Anjali Jameson on hospital and payer alignment.
Read about news from Equiva, DNA Script, Healthmine, Infermedica, and more.